Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Peter Mikolajčík"'
Publikováno v:
Acta Medica, Vol 64, Iss 2, Pp 125-128 (2021)
Hepatolithiasis is a benign disease, where stones are localized proximal to the confluence of hepatic ducts. The clinical picture may differ depending on whether the stones cause complete, partial, or intermittent biliary obstruction. The course can
Externí odkaz:
https://doaj.org/article/f6bf6a157acf490589455f1015f7e172
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Acute kidney injury (AKI) affects approximately 13% of patients undergoing major abdominal surgery, and is a common and important clinical sign of perioperative injury. The aim of our analysis was to identify risk factors for AKI
Externí odkaz:
https://doaj.org/article/14a2c3683ff046ec8ca90b656c45ec1a
Publikováno v:
Acta Medica, Vol 64, Iss 2, Pp 125-128 (2021)
Hepatolithiasis is a benign disease, where stones are localized proximal to the confluence of hepatic ducts. The clinical picture may differ depending on whether the stones cause complete, partial, or intermittent biliary obstruction. The course can
Autor:
Martin Vojtko, Adam Svec, Zora Lasabova, Juraj Marcinek, Ivana Kasubova, Lukáš Plank, Alexander Johannes Wiederhold, Tatiana Burjanivova, Michal Kalman, J Janik, Peter Mikolajčík, Laca L, Marian Grendar, Vincent Lucansky, Eva Kudelova, Dusan Loderer
Publikováno v:
Neoplasma. 68:1331-1340
In colorectal cancer (CRC), clinically relevant biomarkers are known for genome-guided therapy that can be detected by both first and next generation methods. The aim of our work was to introduce a robust NGS assay that will be able to detect, in add
Genomic profile and immune contexture in colorectal cancer—relevance for prognosis and immunotherapy
Autor:
Eva Gabonova, Peter Kruzliak, Zora Lasabova, Peter Sabaka, Michal Kalman, Peter Mikolajčík, Sandra Mersakova, Luis Rodrigo, Rachele Ciccocioppo, Jan Strnadel
Publikováno v:
Clinical and Experimental Medicine. 21:195-204
Colorectal cancer (CRC) is one of the leading cancers in both genders. TNM staging system is still the most commonly used tumor classification and prognostic system. The disadvantage of TNM is that the prognostic information it provides is incomplete
Autor:
Eva Kudelova, Zora Lasabova, Barbora Vanova, Marian Grendar, Zuzana Kolková, Marek Smolar, Erik Kudela, Marek Samec, Laca L, Veronika Holubekova, Peter Mikolajčík
Publikováno v:
Oncology Letters
Colorectal cancer (CRC) is the third-most common cancer type in males and the second-most common cancer type in females, and has the second-highest overall mortality rate worldwide. Approximately 50% of patients in stage I–III develop metastases, m
Autor:
Marian Grendar, Rachele Ciccocioppo, Zora Lasabova, Peter Kruzliak, Peter Mikolajčík, Zuzana Snahnicanova, Luis Rodrigo, Michal Kalman, Laca L, Lukáš Plank, Ivana Kasubova, Eva Gabonova, Martin Caprnda
Publikováno v:
Clinical and experimental medicine. 20(1)
One of the most common mechanisms of immune evasion in MSI colorectal cancers (CRCs) is loss of HLA class I expression due to mutations in B2M gene which can become a negative predictor for checkpoint blockade therapy. The aim of this study was the d
Autor:
Veronika Holubekova, Dusan Loderer, Marian Grendar, Peter Mikolajcik, Zuzana Kolkova, Eva Turyova, Eva Kudelova, Michal Kalman, Juraj Marcinek, Juraj Miklusica, Ludovit Laca, Zora Lasabova
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionColorectal cancer (CRC) is a heterogeneous disease caused by molecular changes, as driver mutations, gene methylations, etc., and influenced by tumor microenvironment (TME) pervaded with immune cells with both pro- and anti-tumor effects.
Externí odkaz:
https://doaj.org/article/7faa164c987947edada577494fd8400d
Autor:
Eva Lukacova, Tatiana Burjanivova, Petar Podlesniy, Marian Grendar, Eva Turyova, Ivana Kasubova, Ludovit Laca, Peter Mikolajcik, Eva Kudelova, Andrea Vanochova, Juraj Miklusica, Sandra Mersakova, Zora Lasabova
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionColorectal cancer (CRC) can develop through several dysregulated molecular pathways, including the serrated pathway, characterized by CpG island methylator (CIMP) phenotype. Although the tumor tissue is a commonly tested material, sample
Externí odkaz:
https://doaj.org/article/0cb6b47d0f0949eaad24dfc414124d57
Autor:
Eva Turyova, Peter Mikolajcik, Marian Grendar, Eva Kudelova, Veronika Holubekova, Michal Kalman, Juraj Marcinek, Matej Hrnciar, Michal Kovac, Juraj Miklusica, Ludovit Laca, Zora Lasabova
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionColorectal cancer (CRC) is one of the most common types of cancer worldwide. The carcinogenesis of CRC is indeed complex, and there are many different mechanisms and pathways that contribute to the development of malignancy and the progre
Externí odkaz:
https://doaj.org/article/9bc9f387778a4f7c983568024f49c8d8